These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10677728)

  • 1. The role of the immune response on the development of severe clinical forms of human Chagas disease.
    Corrêa-Oliveira R; Gomes J; Lemos EM; Cardoso GM; Reis DD; Adad S; Crema E; Martins-Filho OA; Costa MO; Gazzinelli G; Bahia-Oliveira LM
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():253-5. PubMed ID: 10677728
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the cellular immune response in Chagas' disease patients.
    Castes M; Araujo Z; Mosca W
    Acta Cient Venez; 1986; 37(5):547-53. PubMed ID: 3129894
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell mediated immune response in patients with Chagas. Correlation with the presence of Chagasic cardiomyopathy.
    Mosca W; Briceño L
    Biol Res; 1993; 26(1-2):225-31. PubMed ID: 7670535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunopathology of Chagas disease. Facts and perspectives].
    Cossio PM; Diez C; Laguens RP; Arana RM
    Medicina (B Aires); 1980; 40 Suppl 1():222-30. PubMed ID: 6779080
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of aberrant T-cell responses in Chagas disease.
    DosReis GA; Freire-de-Lima CG; Nunes MP; Lopes MF
    Trends Parasitol; 2005 May; 21(5):237-43. PubMed ID: 15837613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological profile in patients with chronic Chagas' disease].
    Bottasso OA; Mangiaterra L; Bravo Luna M; Amerio N; Morini JC
    Medicina (B Aires); 1982; 42(2):136-40. PubMed ID: 6815405
    [No Abstract]   [Full Text] [Related]  

  • 7. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of autoreactive immunological mechanisms in chagasic carditis.
    Ribeiro-dos-Santos R; Pirmez C; Savino W
    Res Immunol; 1991 Feb; 142(2):134-7. PubMed ID: 1678200
    [No Abstract]   [Full Text] [Related]  

  • 9. [A comparison of the cellular immune response and some aspects of its regulation in patients with American cutaneous leishmaniasis and American trypanosomiasis].
    Castés M
    Acta Cient Venez; 1986; 37(4):363-72. PubMed ID: 3122480
    [No Abstract]   [Full Text] [Related]  

  • 10. [The complement system in chronic Chagas disease].
    Riera NE; Malbrán A; Ritacco V; Cossio PM; Arana RM; de Bracco MM
    Medicina (B Aires); 1980; 40(2):125-32. PubMed ID: 6774199
    [No Abstract]   [Full Text] [Related]  

  • 11. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity.
    Souza PE; Rocha MO; Rocha-Vieira E; Menezes CA; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2004 Sep; 72(9):5283-91. PubMed ID: 15322024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology of Trypanosoma cruzi infections.
    Reed SG
    Chem Immunol; 1998; 70():124-43. PubMed ID: 9509673
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA; Rottenberg ME; de Titto EH
    Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-T (Thomsen-Friedenreich) agglutinin in Chagas' disease.
    Palatnik M; Barcinski MA; Krieger H; Laranjeira NS; Loureiro JB
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):312-6. PubMed ID: 3108998
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
    Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the cellular immune response in patients with the digestive and indeterminate forms of Chagas' disease.
    Ribeiro BM; Crema E; Rodrigues V
    Hum Immunol; 2008 Aug; 69(8):484-9. PubMed ID: 18582517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon gamma production by PAS-positive T lymphocytes of chagasic patients infiltrated into human hearts in the sites of lesions.
    Cabral HR; Novak IT; Glocker TM; Castro Viera G
    Rev Fac Cien Med Univ Nac Cordoba; 2006; 63(3):47-52. PubMed ID: 17639817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the presence of Foxp3(+) T cells from patients with different clinical forms of Chagas' disease.
    de Araújo FF; da Silveira AB; Correa-Oliveira R; Chaves AT; Adad SJ; Fiuza JA; Fares RC; Ferreira KS; Fujiwara RT; Silva Gomes JA
    Hum Pathol; 2011 Feb; 42(2):299-301. PubMed ID: 21238788
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific activation of CD4
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
    Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Chagas disease in the mouse. II. Transfer of the heart disease by means of immunocompetent cells.
    Laguens RP; Meckert PC; Chambo G; Gelpi RJ
    Medicina (B Aires); 1981; 41(1):40-3. PubMed ID: 6973684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.